A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
2022-06-27
عنوان الدراسة
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
داعم الدراسة
Takeda
دواء الدراسة
Alogliptin
رقم بروتوكول الدراسة
SYR-322_402
حالة الدراسة
Rejected
موقع الدراسة
PSMMC
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。